Depression scores correlate with glycosylated hemoglobin A levels in type 2 diabetics from a Mayan community

Authors

DOI:

https://doi.org/10.19136/hs.a21n3.4751

Abstract

 

 Objective: To assess whether depression and quality of life scores correlate with glycosylated hemoglobin A (HbA1c) levels in type 2 diabetes mellitus (T2DM) patients of predominant Mayan ethnicity, from a rural community in the state of Yucatán, Mexico.

Materials and methods: Instruments: for depression, CES-D (cutoff ≥ 16); for quality of life, D-39; criterion for poor glycemic control, HbA1c ≥ 8%.

Results: Depression was detected in 36.3% of 33 diabetic subjects (10 men, 23 women), and their HbA1c levels (mean ± SD) were higher (10.7 ± 2.5%) than for those without depression (8.6 ± 2.2%, p = 0.015; unpaired Student’s t-test, two-tailed). Depression occurred in 33.3% of diabetics with HbA1c ≥8%, but only in 3.0% of those with HbA1c < 8% (p = 0.027, Fisher’s exact test). HbA1c levels positively correlated with CES-D scores (r2 =0.135; p = 0.035; Pearson). D-39 “Anxiety-Worry” (AW) dimension scores were higher in diabetics with depression (43.3 ± 22.2) than in those without depression (17.7 ± 17.8; p = 0.005, Mann-Whitney U-test). A positive correlation was found between CES-D and AW scores (r2 = 0.304; p = 0.001; Pearson).

Conclusions: Considering that depression and anxiety have been related to poor self-care for achieving a good glycemic control, we propose the concomitant use of CES-D and D-39, which are validated and easy-to-apply instruments, as screening tests to detect depression and anxiety in T2DM patients residing in rural communities. Therefore, if patients test positive on one or both instruments, they can be referred to a psychiatrist to confirm the diagnosis and provide appropriate therapy. This would help to promote adherence to diabetes control measures and improve their quality of life.

Key words: Diabetes Mellitus, Type 2; Depression; Anxiety; Glycosylated hemoglobin A

Downloads

Download data is not yet available.

Author Biographies

  • José L. Góngora-Alfaro, Universidad Autónoma de Yucatán

    Licenciatura en Médico Cirujano (Universidad Autónoma de Yucatán, 1982)

    Maestría en Ciencias en Farmacología (CINVESTAV-IPN, 1985).

    Doctorado en Ciencias en Fisiología (CINVESTAV-IPN, 1989).

    Integrante del Cuerpo Académico “Estudio Integral de los Trastornos Degenerativos del Sistema Nervioso Central”.

    Acreditado en el Sistema Nacional de Investigadores, Nivel I.

    Acreditado por la Secretaría de Educación como profesor con Perfil PRODEP.

  • Luis Alberto Solís-Díaz, Universidad Autónoma de Yucatán

    Médico Cirujano graduado de la Universidad Autónoma de Yucatán, actualmente residente de tercer año de Medicina Interna en el Hospital Regional de Alta Especialidad de la Península de Yucatán.

  • Fernando José Álvarez-Cervera, Universidad Autónoma de Yucatán

    Licenciatura en Ingeniería Biomédica (Universidad Autónoma Metropolitana, Unidad Iztapalapa.1982)

    Maestría en Ciencias en Ingeniería Biomédica (Tulane University. 1994).

    Integrante del Cuerpo Académico “Estudio Integral de los Trastornos Degenerativos del Sistema Nervioso Central”.

    Acreditado en el Sistema Nacional de Investigadores, Nivel I.

    Acreditado por la Secretaría de Educación como profesor con Perfil PRODEP.

Published

2022-08-31

Issue

Section

Research article

How to Cite

Depression scores correlate with glycosylated hemoglobin A levels in type 2 diabetics from a Mayan community. (2022). Horizonte Sanitario, 21(3), 345-354. https://doi.org/10.19136/hs.a21n3.4751